Birgit Schittek

Dr. Birgit Schittek


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2001 in Nature Immunology
Verified
Journal Article
Closed access
BSBirgit Schittek
Birgit Schittek
RHRainer Hipfel
Rainer Hipfel
BSBirgit Sauer
Birgit Sauer
JBJürgen Bauer
Jürgen Bauer
HKHubert Kalbacher
Hubert Kalbacher
Claus GarbeClaus Garbe
Claus Garbe

1 February 2011 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
IWInes Wanke
Ines Wanke
HSHeiko Steffen
Heiko Steffen
CCChristina Christ
Christina Christ
BKBernhard Krismer
Bernhard Krismer
FGFriedrich Götz
Friedrich Götz
BSBirgit Schittek
Birgit Schittek

11 October 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
BSBirgit Schittek
Birgit Schittek
TSTobias W. Sinnberg
Tobias W. Sinnberg
Isoforms of the casein kinase 1 (CK1) family have been shown to phosphorylate key regulatory molecules involved in cell cycle, transcription and translation, the structure of the cytoskeleton, cell-cell adhesion and receptor-coupled signal transduction. They regulate key signaling pathways known to be critically involved in tumor progression. Recent results point to an altered expression or activity of different CK1 isoforms in tumor cells. This review summarizes the expression and biological function of CK1 family members in normal and malignant cells and the evidence obtained so far about their role in tumorigenesis.

21 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
KBKatharina Bitschar
Katharina Bitschar
BSBirgit Sauer
Birgit Sauer
JFJule Focken
Jule Focken
HDHanna Dehmer
Hanna Dehmer
SMSonja Moos
Sonja Moos
BSBirgit Schittek
Birgit Schittek
Recently our groups discovered lugdunin, a new cyclic peptide antibiotic that inhibits Staphylococcus aureus epithelial colonization in humans and rodents. In this work, we analyzed its immuno-modulatory and antimicrobial potential as a single agent or in combination with other microbiota- or host-derived factors. We show that pretreatment of primary human keratinocytes or mouse skin with lugdunin in combination with microbiota-derived factors results in a significant reduction of S. aureus colonization. Moreover, lugdunin increases expression and release of LL-37 and CXCL8/MIP-2 in human keratinocytes and mouse skin, and results in the recruitment of monocytes and neutrophils in vivo, both by a TLR/MyD88-dependent mechanism. Interestingly, S. aureus elimination by lugdunin is additionally achieved by synergistic antimicrobial activity with LL-37 and dermcidin-derived peptides. In summary, our results indicate that lugdunin provides multi-level protection against S. aureus and may thus become a promising treatment option for S. aureus skin infections in the future.

17 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSTobias W. Sinnberg
Tobias W. Sinnberg
MMMoritz Menzel
Moritz Menzel
DEDaniel Ewerth
Daniel Ewerth
BSBirgit Sauer
Birgit Sauer
MSMichael Schwarz
Michael Schwarz
BSBirgit Schittek
Birgit Schittek
Beta-catenin plays an important role in embryogenesis and carcinogenesis by controlling either cadherin-mediated cell adhesion or transcriptional activation of target gene expression. In many types of cancers nuclear translocation of beta-catenin has been observed. Our data indicate that during melanoma progression an increased dependency on the transcriptional function of beta-catenin takes place. Blockade of beta-catenin in metastatic melanoma cell lines efficiently induces apoptosis, inhibits proliferation, migration and invasion in monolayer and 3-dimensional skin reconstructs and decreases chemoresistance. In addition, subcutaneous melanoma growth in SCID mice was almost completely inhibited by an inducible beta-catenin knockdown. In contrast, the survival of benign melanocytes and primary melanoma cell lines was less affected by beta-catenin depletion. However, enhanced expression of beta-catenin in primary melanoma cell lines increased invasive capacity in vitro and tumor growth in the SCID mouse model. These data suggest that beta-catenin is an essential survival factor for metastatic melanoma cells, whereas it is dispensable for the survival of benign melanocytes and primary, non-invasive melanoma cells. Furthermore, beta-catenin increases tumorigenicity of primary melanoma cell lines. The differential requirements for beta-catenin signaling in aggressive melanoma versus benign melanocytic cells make beta-catenin a possible new target in melanoma therapy.

1 March 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MPMaren Paulmann
Maren Paulmann
TAThomas Arnold
Thomas Arnold
DLDirk Linke
Dirk Linke
SÖSuat Özdirekcan
Suat Özdirekcan
AKAnnika Kopp
Annika Kopp
BSBirgit Schittek
Birgit Schittek
Dermcidin encodes the anionic amphiphilic peptide DCD-1L, which displays a broad spectrum of antimicrobial activity under conditions resembling those in human sweat. Here, we have investigated its mode of antimicrobial activity. We found that DCD-1L interacts preferentially with negatively charged bacterial phospholipids with a helix axis that is aligned flat on a lipid bilayer surface. Upon interaction with lipid bilayers DCD-1L forms oligomeric complexes that are stabilized by Zn2+. DCD-1L is able to form ion channels in the bacterial membrane, and we propose that Zn2+-induced self-assembly of DCD-1L upon interaction with bacterial lipid bilayers is a prerequisite for ion channel formation. These data allow us for the first time to propose a molecular model for the antimicrobial mechanism of a naturally processed human anionic peptide that is active under the harsh conditions present in human sweat.